Bio-Rad Laboratories Inc (BIO)
332.01
+6.43
(+1.97%)
USD |
NYSE |
Nov 22, 14:57
Bio-Rad Laboratories Total Liabilities (Quarterly): 3.116B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 3.116B |
| June 30, 2024 | 2.910B |
| March 31, 2024 | 3.559B |
| December 31, 2023 | 3.558B |
| September 30, 2023 | 3.480B |
| June 30, 2023 | 3.531B |
| March 31, 2023 | 3.904B |
| December 31, 2022 | 3.886B |
| September 30, 2022 | 3.605B |
| June 30, 2022 | 3.760B |
| March 31, 2022 | 4.191B |
| December 31, 2021 | 4.114B |
| September 30, 2021 | 4.621B |
| June 30, 2021 | 3.523B |
| March 31, 2021 | 3.324B |
| December 31, 2020 | 3.093B |
| September 30, 2020 | 3.196B |
| June 30, 2020 | 2.744B |
| March 31, 2020 | 2.391B |
| December 31, 2019 | 2.254B |
| September 30, 2019 | 2.046B |
| June 30, 2019 | 2.160B |
| March 31, 2019 | 1.999B |
| December 31, 2018 | 1.591B |
| September 30, 2018 | 1.818B |
| Date | Value |
|---|---|
| June 30, 2018 | 1.747B |
| March 31, 2018 | 1.727B |
| December 31, 2017 | 1.343B |
| September 30, 2017 | 1.337B |
| June 30, 2017 | 1.332B |
| March 31, 2017 | 1.245B |
| December 31, 2016 | 1.271B |
| September 30, 2016 | 1.317B |
| June 30, 2016 | 1.260B |
| March 31, 2016 | 1.209B |
| December 31, 2015 | 1.219B |
| September 30, 2015 | 1.237B |
| June 30, 2015 | 1.166B |
| March 31, 2015 | 1.128B |
| December 31, 2014 | 1.156B |
| September 30, 2014 | 1.209B |
| June 30, 2014 | 1.218B |
| March 31, 2014 | 1.209B |
| December 31, 2013 | 1.202B |
| September 30, 2013 | 1.156B |
| June 30, 2013 | 1.412B |
| March 31, 2013 | 1.426B |
| December 31, 2012 | 1.428B |
| September 30, 2012 | 1.368B |
| June 30, 2012 | 1.316B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.254B
Minimum
Dec 2019
4.621B
Maximum
Sep 2021
3.438B
Average
3.527B
Median
Total Liabilities (Quarterly) Benchmarks
| Agilent Technologies Inc | 5.093B |
| Bruker Corp | 4.270B |
| Azenta Inc | 331.07M |
| Harvard Bioscience Inc | 65.92M |
| Bionano Genomics Inc | 38.49M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 10.60B |
| Shareholders Equity (Quarterly) | 7.488B |
| Debt to Equity Ratio | 0.1604 |
| Current Ratio | 6.136 |
| Net Debt Paydown Yield | -0.01% |